Saquinavir Mesylate

甲磺酸沙奎那韦

Report date: 2022/09/07 17:51:59
NME

Base Information

Drug NameSaquinavir Mesylate
Drug Alias NameSaquinavir甲磺酸沙喹那韦甲磺酸噻喹努佛Saquinavirum赛科纳瓦 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1995/12/06
Country/TerritoryUnited StatesEUMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co LtdShanghai Luoshi Pharmaceutical Co Ltd Beijing Office
Inactive CompaniesF. Hoffmann-La Roche AgStanford UniversityF. Hoffmann-La Roche Ltd +[4] 
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05AE01
Related LinksWikipediaDrugBankKEGG